期刊
TUMOR BIOLOGY
卷 36, 期 3, 页码 1403-1409出版社
SAGE PUBLICATIONS LTD
DOI: 10.1007/s13277-015-3267-8
关键词
Non-coding RNA; miR-100; Human cancer; Diagnostic; Prognostic; Biomarker
类别
资金
- National Natural Science Foundation of China [81272601, 81472198]
- Key Clinical Medicine Technology Foundation of Jiangsu Province [BL2014096]
- Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project [RC2011080]
- Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University [CX201202]
- 333 high class Talented Man Project [2011-III-2630]
MicroRNAs (miRNAs) are small non-coding RNAs that function by base pairing with messenger RNAs, thereby regulating protein expression. Functional studies indicate that miRNAs are involved in the regulation of almost every biological pathway. Moreover, changes in miRNA expression are associated with several human pathologies, including cancer. Dysregulation and aberrant expression of microRNA-100 (miR-100) have been reported to be involved in tumorigenesis and tumor progression of several cancer types, suggesting that miR-100 might serve as a diagnostic and/or prognostic marker for human malignancy. In this review, we summarize the potential application of miR-100 in cancer treatment and as a new molecular marker for cancer prognosis and diagnosis. We will provide a brief introduction to miR-100 and discuss its role as a non-invasive biomarker and a potential therapeutic target in human cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据